Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-18 07:00 |
Le vaccin IXCHIQ® de Valneva contre le chikungunya désormais autorisé au Canada…
|
French | 191.3 KB | ||
| 2025-08-12 07:00 |
VALNEVA : Rapport Semestriel 2025
|
French | 1.1 MB | ||
| 2025-08-12 07:00 |
Valneva publie ses résultats financiers du premier semestre 2025 et fait un poi…
|
French | 339.1 KB | ||
| 2025-08-12 07:00 |
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
|
English | 415.7 KB | ||
| 2025-08-07 07:17 |
Valneva annonce la levée de l’arrêt temporaire de la FDA sur l’utilisation du v…
|
French | 218.7 KB | ||
| 2025-08-07 07:17 |
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccin…
|
English | 222.5 KB | ||
| 2025-08-05 18:00 |
VALNEVA Déclaration d’actions et de droits de vote : 31 juillet 2025
|
French | 200.9 KB | ||
| 2025-08-05 18:00 |
VALNEVA Declaration of shares and voting rights: July 31, 2025
|
English | 210.4 KB | ||
| 2025-07-11 17:35 |
Valneva annonce la levée de la restriction temporaire de l'Agence européenne de…
|
French | 165.8 KB | ||
| 2025-07-11 17:35 |
Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction …
|
English | 208.0 KB | ||
| 2025-07-03 18:00 |
VALNEVA Déclaration d’actions et de droits de vote : 30 juin 2025
|
French | 160.7 KB | ||
| 2025-07-03 18:00 |
VALNEVA Declaration of shares and voting rights: June 30, 2025
|
English | 52.7 KB | ||
| 2025-06-26 07:00 |
Valneva annonce un accord exclusif avec CSL Seqirus pour le marketing et la dis…
|
French | 142.1 KB | ||
| 2025-06-26 07:00 |
Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Ge…
|
English | 153.5 KB | ||
| 2025-06-25 17:45 |
Valneva annonce l’approbation des résolutions présentées à son Assemblée Généra…
|
French | 145.4 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
